Aug 15
Opportunity
Clinical trial participants and their care partners often do not feel valued for their contribution to clinical trials, which may impact retention, participant satisfaction, and overall adherence. Receiving an act of appreciation (e.g., a thank you card / letter) during a clinical trial is directly related to overall satisfaction with the clinical trial.
Considerations to Help Action the Opportunity
- Include decisions around gratitude as part of the engagement strategy early in the clinical development planning process
- Understand which tools and templates are most appropriate to your study and patient population
- Test gratitude tools with the patient population
- Define distribution methods and understand how use of decentralized trials / platforms may impact which format is used
- Identify opportunities to evaluate the value of the tactics and how they were received by participants / care partners (e.g., incorporating questions regarding gratitude into the SPFQ or similar patient feedback questionnaire)
Value and Potential Benefits
- Improves recruitment from word-of-mouth referrals by participants speaking positively about their experience in clinical trials
- Improves engagement, adherence, and compliance by recognizing the time and effort participants contribute to the clinical trial
- Increases participant’s satisfaction and perceived value of their clinical trial journey by recognizing the value of their experience
- Improves relationships with clinical research staff by recognizing the important relationship they develop with the patient and work needed to make the trial successful at their site
- Improves industry reputation and trust in clinical research
Related Blog Posts
Redesigning Clinical Trials Using Artificial Intelligence
While tech evangelists often tout artificial intelligence (AI) as healthcare’s silver bullet, the reality in clinical trials is more complex. Adoption has been cautious, shaped as much by concerns around trust and governance as by technical hurdles. Still, beneath the surface, methodical innovation is gaining momentum. AI is beginning to reshape how trials are designed,…
How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials
It’s hard to believe that just five years ago, the clinical research industry found itself scrambling to adapt overnight. The COVID-19 pandemic ground global health systems to a halt and forced us all to move faster and more collaboratively than ever before. Read the full article by Allison Cuff Shimooka from The Medicine Maker here.
Science is Moving—Clinical Trials Must Catch Up
Clinical research has never been more capable of reaching new frontiers. The science is here. The technology is here. But the approach to trial design and execution hasn’t kept pace. The clinical research ecosystem proceeds cautiously for good reasons—patient safety chief among them. But too often, we’re held back by fixed mindsets and outdated processes.…